EIF in conjuction with www.map.com.
Map pharmecueticals ,will be conducting human trials
regarding inhaled insulin and an improved asthma delivery system using eiffeltechnology nano particles.
map pharmecueticals have recieved a US 25 Million dollars grant.
Also inhaled insulin has been approved in Europe, matter of time that EIF AND MAP capture the US market.
At these prices excellent entry point.One to put on
your watch list.
Have been involved with EIF for along time.
- Forums
- ASX - By Stock
- opportunity for 500% increase
EIF
eiffel technologies limited
EIF in conjuction with www.map.com.Map pharmecueticals ,will be...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ron Miller, Non-Executive Director
Ron Miller
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online